Gain Therapeutics Inc (GANX) SEC filings

Gain Therapeutics Inc (GANX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported GANX revenue for 2023-09-30 was $55.2K. Net income was -$4.7M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. GANX currently screens at market cap $53.0M. The GANX filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Gain Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.